ECM
IRWD icon

EMC Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

EMC Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$28K Sell
8,386
-1,480
-15% -$3.84K 0.01% 276
2025
Q3 		$13K Hold
9,866
– – 0.01% 296
2025
Q2 		$7K Sell
9,866
-14,027
-59% -$11K ﹤0.01% 298
2025
Q1 		$35K Hold
23,893
– – 0.02% 263
2024
Q4 		$106K Buy
23,893
+20,880
+693% +$84.7K 0.06% 226
2024
Q3 		$225K Sell
3,013
-20,880
-87% -$112K 0.15% 138
2024
Q2 		$156K Hold
23,893
– – 0.09% 194
2024
Q1 		$208K Sell
23,893
-19,422
-45% -$236K 0.12% 160
2023
Q4 		$496K Hold
43,315
– – 0.33% 29
2023
Q3 		$417K Buy
43,315
+41,338
+2,091% +$405K 0.31% 33
2023
Q2 		$121 Sell
1,977
-41,338
-95% -$444K 0.09% 197
2023
Q1 		$456K Hold
43,315
– – 0.38% 27
2022
Q4 		$537K Buy
43,315
+5,558
+15% +$63K 0.48% 12
2022
Q3 		$391K Hold
37,757
– – 0.36% 24
2022
Q2 		$435K Buy
37,757
+12,821
+51% +$151K 0.37% 24
2022
Q1 		$299K Buy
+24,936
New +$286K 0.21% 60

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EMC Capital Management's IRWD Position: Q4 2025 in Review

EMC Capital Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 15% in Q4 2025, selling an estimated $3.84K and leaving 8,386 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #276.

EMC Capital Management first reported a position in IRWD in Q1 2022 and has held it in 16 quarters since. The position peaked at $537K in Q4 2022. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2025.

  • EMC Capital Management held 8,386 shares of Ironwood Pharmaceuticals worth $28K as of Q4 2025.
  • EMC Capital Management sold 1,480 Ironwood Pharmaceuticals shares in Q4 2025, an estimated $3.84K.
  • Ironwood Pharmaceuticals made up 0.01% of EMC Capital Management's portfolio in Q4 2025, its #276 holding.
  • EMC Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • EMC Capital Management's Ironwood Pharmaceuticals position peaked at $537K in Q4 2022.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.